Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with “idiopathic” interstitial lung disease

Clin Immunol. 2024 Apr 2:262:110201. DOI: 10.1016/j.clim.2024.110201 Online ahead of print.

Sarah L Tansley, Fionnuala McMorrow, Caroline V Cotton, Huzaifa Adamali, Shaney L Barratt, Zoe E Betteridge, Janire Perurena-Prieto, Michael A Gibbons, Raman Kular, Aravinthan Loganathan, Janine A Lamb, Hui Lu, Robert P New, Diane Pratt, Pilar Rivera-Ortega, Ross Sayers, Matthew Steward, Lachlan Stranks, Edward Vital, Lisa G Spencer, Neil J McHugh, Robert G Cooper; UK-BILD Collaboration

https://pubmed.ncbi.nlm.nih.gov/38575043

Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases

Front Med (Lausanne). 2023 Feb 15;10:1114722. DOI: 10.3389/fmed.2023.1114722 eCollection 2023.

Stefan Cristian Stanel, Pilar Rivera-Ortega

https://pubmed.ncbi.nlm.nih.gov/36873896/

Imaging biomarkers of lung ventilation in interstitial lung disease from 129Xe and oxygen enhanced 1H MRI

Magn Reson Imaging. 2023 Jan;95:39-49. DOI: 10.1016/j.mri.2022.10.005

Marta Tibiletti, James A Eaden, Josephine H Naish, Paul J C Hughes, John C Waterton, Matthew J Heaton, Nazia Chaudhuri, Sarah Skeoch, Ian N Bruce, Stephen Bianchi, Jim M Wild, Geoff J M Parker

https://pubmed.ncbi.nlm.nih.gov/36252693/

PAciFy Cough-a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough

Trials. 2022 Mar 2;23(1):184. DOI: 10.1186/s13063-022-06068-4

Zhe Wu, Winston Banya, Nazia Chaudhuri, Ira Jakupovic, Toby M Maher, Brijesh Patel, Lisa G Spencer, Muhunthan Thillai, Alex West, John Westoby, Marlies Wijsenbeek, Jaclyn Smith, Philip L Molyneaux

https://pubmed.ncbi.nlm.nih.gov/35236391/

The impact of lung parenchyma attenuation on nodule volumetry in lung cancer screening

Insights Imaging. 2021 Jun 25;12(1):84. DOI: 10.1186/s13244-021-01027-0

Diana Penha, Erique Pinto, Bruno Hochhegger, Colin Monaghan, Edson Marchiori, Luís Taborda-Barata, Klaus Irion

https://pubmed.ncbi.nlm.nih.gov/34170410/

Response to: ‘Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future’ by Wang et al

 

Ann Rheum Dis. 2020 Aug 5;annrheumdis-2020-218712. doi: 10.1136/annrheumdis-2020-218712. Online ahead of print.

Janine A Lamb, Spyridon Megremis, Hector Chinoy

https://pubmed.ncbi.nlm.nih.gov/32759262/

The Extended Utility of Antifibrotic Therapy in Progressive Fibrosing Interstitial Lung Disease

Expert Rev Respir Med. 2020 Jun 22. DOI: 10.1080/17476348.2020.1784730. Online ahead of print.

Paroma Sarkar, Cristina Avram, Nazia Chaudhuri

https://pubmed.ncbi.nlm.nih.gov/32567402/

How consistently do physicians diagnose and manage drug-induced interstitial lung disease? Two surveys of European ILD specialist physicians

ERJ Open Res. 2020 Mar 16;6(1). pii: 00286-2019. DOI: 10.1183/23120541.00286-2019. eCollection 2020 Jan.

Eaden JA, Skeoch S, Waterton JC, Chaudhuri N, Bianchi SM.

https://www.ncbi.nlm.nih.gov/pubmed/32201691

Transbronchial Lung Cryobiopsy in Idiopathic Pulmonary Fibrosis: A State of the Art Review

Adv Ther. 2019 Sep;36(9):2193-2204. DOI: 10.1007/s12325-019-01036-y. Epub 2019 Jul 30.

Lodhi T, Hughes G, Stanel S, Chaudhuri N, Hayton C.

https://www.ncbi.nlm.nih.gov/pubmed/31363997

Idiopathic Pulmonary Fibrosis (IPF): An Overview

J Clin Med. 2018 Aug 6;7(8). pii: E201. DOI: 10.3390/jcm7080201.

Barratt SL, Creamer A, Hayton C, Chaudhuri N.

https://www.ncbi.nlm.nih.gov/pubmed/30082599